Speaker

Gordon Sanghera

CEO

Oxford Nanopore

About Gordon

Gordon Sanghera, CEO of Oxford Nanopore, the company that made the first ever portable DNA sequencer, used to sequence the genome of COVID-19 in China, which is now making machines for mass screening of coronavirus. Dr Sanghera’s PhD in bioelectronics sensing was followed by a career at MediSense an Oxford spin-out that delivered a new generation glucose technology to the market. Following the acquisition of MediSense by Abbott Laboratories Dr Sanghera held both UK and US VP and Director-level positions, including VP World Wide Marketing, Research Director and Manufacturing Process Development Director. Before its acquisition by Abbott, Gordon led the R&D of Medisense Inc. where he was instrumental in the launch of several generations of blood glucose bio-electronic systems for the consumer and hospital medical markets. He has also developed and validated production processes to meet with the regulatory requirements for USA and Europe.

Topic